Proprietary Forecast Model Stands Up To Scrutiny For Third Year Running

BMI View: Bangladesh has a very attractive but fundamentally flawed pharmaceutical market. Combined sales of prescription drugs and over-the-counter (OTC) medicines in the South Asian country saw the seventh fastest expansion in the world in 2010, at 21.9% - ahead of Qatar (+21.0%) but behind Venezuela (+22.2%). However, due to Bangladesh's patent-free regime, demand for medicines is artificially inflated and prejudiced against multinational firms. A deceleration of economic growth in 2011 and under-appreciated political risk are further disincentives to foreign direct investment.

To read the full article, please choose one of the following options: